Semaglutide 2 mg
US$ 26.76
glp-1/fgf21 agonist boehringer GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Alimentary Pharmacology & Therapeutics |
Description
And that is quite unpleasant
Researchers reported that nearly 90% of participants who took the medication achieved an HbA1c level of 7%, the standard target for average blood glucose levels
10.2337/diabetes.49.4.611 125 WajchenbergB
GLP-1s also conferred a lower risk for hospitalization, pneumonia, heart-related events and sepsis
Lisco G, De Tullio A, Disoteo O, De Geronimo V, Piazzolla G, De Pergola G, Giagulli VA, Jirillo E, Guastamacchia E, Sabba C, et al
